APY0201 is primarily utilized in research settings as a potent and selective inhibitor targeting specific cellular pathways. It is often employed in biochemical and pharmacological studies to investigate the role of certain enzymes or signaling pathways in disease mechanisms, particularly in cancer research. By inhibiting these pathways, APY0201 helps researchers understand cellular processes and evaluate potential therapeutic strategies. Its application extends to in vitro and in vivo experiments, where it aids in exploring drug efficacy and identifying novel treatment targets. Additionally, APY0201 is used in high-throughput screening assays to discover and develop new compounds with therapeutic potential.